Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Co-Diagnostics has raised $3.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Co-Diagnostics's investors include Bill & Melinda Gates Foundation, National Institutes of Health, Maxim Group.
Co-Diagnostics is headquartered in Salt Lake City, United States.
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Co-Diagnostics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Co-Diagnostics — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/co-diagnostics. Accessed July 19, 2026.
VCBacked. (2026). Co-Diagnostics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/co-diagnostics
{{cite web |title=Co-Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/co-diagnostics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated